Makes placental allografts for chronic wound care.
Jun 2026Revenue $355M/yrExpenses $346M/yr
No trend
Figures by year
Is Mimedx Group profitable?
Yes. In the 12 months to Jun 2026, revenue was $355M and expenses $346M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $419M | $355M | $63.9M |
| Dec 2024 | $349M | $290M | $58.9M |
| Dec 2023 | $321M | $284M | $37.1M |
| Dec 2022 | $268M | $283M | −$14.7M |
| Dec 2021 | $242M | $249M | −$7.05M |
| Dec 2020 | $248M | $294M | −$45.4M |
| Dec 2019 | $299M | $320M | −$21.2M |
| Dec 2018 | $359M | $363M | −$3.92M |
| Dec 2017 | $321M | $275M | $46.2M |
| Dec 2016 | $222M | $221M | $884K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.